Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Biochemical and Biophysical Research Communications|August 15, 2022
SARS-CoV-2 spike S1 subunit protein-mediated increase of beta-secretase 1 (BACE1) impairs human brain vessel cellsJi-Young Choi, Jung Hyun Park, Chulman Jo, et al.BMC Medical Genomics|January 11, 2019
Meta-analysis of gene expression profiles in long-term non-progressors infected with HIV-1Sun Young Lee, Yong Kwang Park, Cheol-Hee Yoon, et al.Intervirology|June 6, 2013
Histone deactylase inhibitor SAHA induces a synergistic HIV-1 reactivation by 12-O-tetradecanoylphorbol-13-acetate in latently infected cellsSoon Young Park, Kyung-Chang Kim, Kee-Jong Hong, et al.Journal of Virological Methods|August 16, 2017
Development of a dual reporter screening assay for distinguishing the inhibition of HIV Tat-mediated transcription from off-target effectsYoungHyun Shin, Byeong-Sun Choi, Kyung-Chang Kim, et al.Antiviral Research|April 22, 2023
Evaluation of antiviral drugs against newly emerged SARS-CoV-2 Omicron subvariantsJunhyung Cho, Younmin Shin, Jeong-Sun Yang, et al.Genomics|February 18, 2018
Selection of biomarkers for HIV-1 latency by integrated analysisSun Young Lee, Byeong-Sun Choi, Cheol-Hee Yoon, et al.Virus Research|November 7, 2016
Synergistic reactivation of latent HIV-1 provirus by PKA activator dibutyryl-cAMP in combination with an HDAC inhibitorHoyong Lim, Kyung-Chang Kim, Junseock Son, et al.Human Genomics|May 14, 2017
Identification of novel genes associated with HIV-1 latency by analysis of histone modificationsKyung-Chang Kim, Sunyoung Lee, Junseock Son, et al.Virology Journal|August 17, 2016
Highly activated p53 contributes to selectively increased apoptosis of latently HIV-1 infected cells upon treatment of anticancer drugsYoungHyun Shin, Hoyong Lim, Byeong-Sun Choi, et al.Vaccines|November 11, 2022
Comparing the Immunogenicity and Protective Effects of Three MERS-CoV Inactivation Methods in MiceNayoung Kim, Tae-Young Lee, Hansaem Lee, et al.Pageof 5